Humanitas Global Health Launches in New Orleans: Signs DeepDrug Technology License With Louisiana State University
NEW ORLEANS, Orleans Parish, Louisiana — Newly launched health technology company Humanitas Global Health announced its launch on October 27 at the AAPS PharmSci 360 conference in New Orleans (October 25-28, Morial Convention Center), together with a commercialization license for the DeepDrug technology from Louisiana State University (LSU). DeepDrug is a superintelligence (SI) drug-discovery technology developed by an LSU team.
The company's founder and CEO is Chris Galliano. On October 27 the company hosted a panel session at the conference; that afternoon, the LSU and DeepDrug team was honored at the Louisiana Biotech Innovation Award ceremony, which the company attended.
Source: GSM · USA
Source: GSM · USA (original Chinese edition)
Photo: 图：新奥尔良 Ernest N. Morial 会议中心（Barry Bahler 摄，公共领域，美国联邦紧急事务管理局，Wikimedia Commons）。The Ernest N. Morial Convention Center in New Orleans (by Barry Bahler, public domain, FEMA, via Wikimedia Commons).
